advertisement
02 September 2010

Botox maker to pay $600 million

Allergan, the maker of the popular anti-wrinkle treatment Botox, has agreed to pay $600 million to settle a probe into illegal marketing for so-called off-label uses.

Allergan, the maker of the popular anti-wrinkle treatment Botox, has agreed to pay $600 million (about R4.3 billion) to settle a US probe into illegal marketing for so-called off-label uses.

The misbranding case stems from the promotion of Botox for uses for which it had not been approved between 2000 and 2005, the company said. During that time, its marketing resulted in uses for headache, pain, spasticity and juvenile cerebral palsy. Some of those uses were subsequently approved or are being considered.

 
NEXT ON HEALTH24X
advertisement

Read Health24’s Comments Policy

Comment on this story
0 comments
Comments have been closed for this article.

Live healthier

Lifestyle »

E-cigarettes: Here are five things to know

E-cigarettes have become hugely popular in the past decade, but a rash of vaping-linked deaths and illnesses in the US is feeding caution about a product that's already banned in some places.

Allergy »

Ditch the itch: Researchers find new drug to fight hives

A new drug works by targeting an immune system antibody called immunoglobulin E, which is responsible for the allergic reaction that causes hives.